Why Medpace (MEDP) Outpaced the Stock Market Today

Medpace (MEDP) closed the most recent trading day at $466.80, moving +1.32% from the previous trading session. The stock's change was more than the S&P 500's daily gain of 0.54%. Elsewhere, the Dow gained 0.66%, while the tech-heavy Nasdaq added 0.77%.

Coming into today, shares of the provider of outsourced clinical development services had gained 4.19% in the past month. In that same time, the Medical sector lost 8.43%, while the S&P 500 lost 4.71%.

The investment community will be closely monitoring the performance of Medpace in its forthcoming earnings report. The company is scheduled to release its earnings on April 22, 2026. It is anticipated that the company will report an EPS of $3.74, marking a 1.91% rise compared to the same quarter of the previous year. Our most recent consensus estimate is calling for quarterly revenue of $694.24 million, up 24.29% from the year-ago period.

MEDP's full-year Zacks Consensus Estimates are calling for earnings of $17.04 per share and revenue of $2.81 billion. These results would represent year-over-year changes of +11.52% and +11.17%, respectively.

Investors might also notice recent changes to analyst estimates for Medpace. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability.

Our research reveals that these estimate alterations are directly linked with the stock price performance in the near future. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.

Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate remained stagnant within the past month. Medpace is currently sporting a Zacks Rank of #3 (Hold).

Investors should also note Medpace's current valuation metrics, including its Forward P/E ratio of 27.04. This signifies a premium in comparison to the average Forward P/E of 15.02 for its industry.

Meanwhile, MEDP's PEG ratio is currently 2.21. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. As the market closed yesterday, the Medical Services industry was having an average PEG ratio of 1.38.

The Medical Services industry is part of the Medical sector. With its current Zacks Industry Rank of 95, this industry ranks in the top 39% of all industries, numbering over 250.

The Zacks Industry Rank assesses the vigor of our specific industry groups by computing the average Zacks Rank of the individual stocks incorporated in the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.

Remember to apply Zacks.com to follow these and more stock-moving metrics during the upcoming trading sessions.

Radical New Technology Could Hand Investors Huge Gains

Quantum Computing is the next technological revolution, and it could be even more advanced than AI.

While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.

Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.

Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.

See Top Quantum Stocks Now >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Medpace Holdings, Inc. (MEDP): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research